PLUS1
165.11
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
| Volume | 521 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Johnson and Johnson | JNJ | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 165.11 | 08:41:15 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 165.11 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 117 | 521 | - | 155.72 - 186.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:42:26 | 2 | $ 164.53 | USD |
Period:
Draw Mode:
Johnson and Johnson Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 434.10B | 2.63B | 2.63B | $ 93.78B | $ 19.07B | 7.81 | 23.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 4.19 | 2.73% | 08/22/22 | 900.00 | 0.20% |
Johnson and Johnson News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JNJ Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 166.48 | 167.17 | 161.70 | 164.17 | 7,083,904 | -1.37 | -0.82% |
| 1 Month | 163.88 | 167.67 | 160.81 | 165.27 | 8,141,338 | 1.23 | 0.75% |
| 3 Months | 172.53 | 178.51 | 160.81 | 167.45 | 7,133,171 | -7.42 | -4.3% |
| 6 Months | 179.00 | 186.69 | 160.81 | 173.34 | 7,269,618 | -13.89 | -7.76% |
| 1 Year | 159.87 | 186.69 | 155.72 | 170.17 | 7,474,357 | 5.24 | 3.28% |
| 3 Years | 133.27 | 186.69 | 109.16 | 156.91 | 7,513,718 | 31.84 | 23.89% |
| 5 Years | 133.00 | 186.69 | 109.16 | 148.49 | 7,192,018 | 32.11 | 24.14% |
Johnson and Johnson Description
| Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States. |
